Risk factors for acute renal insufficiency in patients with suspected or documented bacterial pneumonia.
OBJECTIVE
To describe the incidence of acute renal insufficiency and identify potential risk factors associated with this adverse medical event.


METHODS
A cohort analytic study of patients with documented or suspected bacterial pneumonia.


METHODS
Nationwide survey of 74 acute care hospitals across the US.


METHODS
A total of 1822 adult patients with documented or suspected bacterial pneumonia who were receiving a cephalosporin, penicillin, or an aminoglycoside were enrolled. Patients were excluded if the duration of antimicrobial therapy was < 3 days or if the pneumonia was judged to be nonbacterial.


METHODS
Clinical pharmacists completed standardized data collection forms on all patients enrolled in the study. Information regarding patient demographics, concurrent illnesses and medications, antibiotic administration, representative laboratory data, and the occurrence of any adverse clinical event was specifically captured. Information regarding the development of acute renal insufficiency was targeted as an event to be captured.


METHODS
Univariate and multivariate analyses were performed to identify significant risk factors for acute renal insufficiency. A subset analysis was similarly performed to identify risk factors associated with aminoglycoside-related acute renal insufficiency.


RESULTS
Of the patients enrolled in this study, 8.2 percent developed acute renal insufficiency. Risk factors for acute renal insufficiency included renal disease, aminoglycoside therapy, nosocomial pneumonia, elevated estimated creatinine clearance prior to study entry, cardiac arrest/shock, congestive heart failure, total duration of antibiotics > 7 days, clindamycin therapy, liver disease, and first-generation cephalosporin usage. Risk factors for aminoglycoside-related acute renal insufficiency identified via multiple logistic regression included amphotericin B, congestive heart failure, aminoglycoside trough concentration > 1.5 mg/L, and clindamycin therapy.


CONCLUSIONS
The risk factors identified for acute renal insufficiency suggest that severity of illness strongly influences the development of renal insufficiency. Theoretically, the results of this study could serve as a framework for developing risk prevention programs within individual hospitals. Specific risk factors could be identified for a patient population and risk factors that could be modified could then be targeted for intervention. This type of information can also assist clinicians in predicting the probability of the adverse event for a particular patient and subsequently minimizing this risk by initiating intense monitoring or modifying the drug regimen.
Welage
L S
LS
College of Pharmacy, University of Michigan, Ann Arbor.
Walawander
C A
CA
Timm
E G
EG
Grasela
T H
TH
D058186:Acute Kidney Injury / Q000453:epidemiology / Q000209:etiology*; D000368:Aged; D000369:Aged, 80 and over; D000617:Aminoglycosides; D000666:Amphotericin B / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy; D015331:Cohort Studies; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000150:complications* / Q000188:drug therapy; D011159:Population Surveillance; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000666:Amphotericin B